Study Evaluating the Pharmacokinetics of a Single Microdose of ACD856
Status:
Completed
Trial end date:
2020-04-18
Target enrollment:
Participant gender:
Summary
This is a Phase 0, open-label, non-controlled, single-centre study designed to evaluate the
pharmacokinetics (PK) and safety and tolerability of a single, bolus intravenous (iv)
injection of a microdose of ACD856 in healthy subjects.